BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,209,437 | +1.2% | 83,017 | -1.2% | 0.02% | -10.5% |
| Q3 2023 | $3,171,066 | -11.3% | 84,024 | +7.1% | 0.02% | -9.5% |
| Q2 2023 | $3,575,048 | -43.3% | 78,469 | -49.5% | 0.02% | -47.5% |
| Q1 2023 | $6,308,621 | -7.3% | 155,538 | +16.5% | 0.04% | -16.7% |
| Q4 2022 | $6,806,738 | -99.9% | 133,544 | -28.1% | 0.05% | -37.7% |
| Q3 2022 | $9,999,486,000 | +91.5% | 185,657 | +128.4% | 0.08% | +108.1% |
| Q2 2022 | $5,222,027,000 | -13.5% | 81,302 | +4.4% | 0.04% | +2.8% |
| Q1 2022 | $6,036,489,000 | -11.2% | 77,850 | -1.7% | 0.04% | -10.0% |
| Q4 2021 | $6,796,554,000 | +10.3% | 79,177 | +3.3% | 0.04% | 0.0% |
| Q3 2021 | $6,162,868,000 | +3.8% | 76,624 | +3.8% | 0.04% | +2.6% |
| Q2 2021 | $5,939,612,000 | +1.3% | 73,784 | +6.1% | 0.04% | -9.3% |
| Q1 2021 | $5,862,473,000 | +18.7% | 69,510 | +12.9% | 0.04% | 0.0% |
| Q4 2020 | $4,939,013,000 | +3.4% | 61,553 | +3.6% | 0.04% | -15.7% |
| Q3 2020 | $4,776,626,000 | -2.4% | 59,396 | +4.5% | 0.05% | -10.5% |
| Q2 2020 | $4,894,613,000 | +20.1% | 56,848 | +13.2% | 0.06% | -5.0% |
| Q1 2020 | $4,076,388,000 | -18.1% | 50,208 | -15.7% | 0.06% | +22.4% |
| Q4 2019 | $4,980,156,000 | +10.1% | 59,557 | +15.2% | 0.05% | -3.9% |
| Q3 2019 | $4,522,986,000 | +13.2% | 51,709 | +6.0% | 0.05% | +10.9% |
| Q2 2019 | $3,996,474,000 | -9.9% | 48,797 | -10.6% | 0.05% | -9.8% |
| Q1 2019 | $4,436,680,000 | +12.7% | 54,565 | -8.8% | 0.05% | 0.0% |
| Q4 2018 | $3,936,694,000 | -23.6% | 59,810 | -10.5% | 0.05% | -12.1% |
| Q3 2018 | $5,151,077,000 | +6.8% | 66,819 | +2.3% | 0.06% | +1.8% |
| Q2 2018 | $4,823,820,000 | +26.9% | 65,328 | +11.8% | 0.06% | +23.9% |
| Q1 2018 | $3,800,157,000 | +8.0% | 58,428 | +7.3% | 0.05% | +9.5% |
| Q4 2017 | $3,518,226,000 | +4.7% | 54,428 | +1.7% | 0.04% | -6.7% |
| Q3 2017 | $3,358,882,000 | +1.9% | 53,528 | -1.7% | 0.04% | -6.2% |
| Q2 2017 | $3,295,071,000 | +13.6% | 54,428 | -2.7% | 0.05% | +4.3% |
| Q1 2017 | $2,900,426,000 | -46.3% | 55,928 | -54.1% | 0.05% | -53.5% |
| Q4 2016 | $5,397,420,000 | +30.6% | 121,728 | +40.2% | 0.10% | +22.2% |
| Q3 2016 | $4,133,013,000 | -56.8% | 86,828 | -58.9% | 0.08% | -60.1% |
| Q2 2016 | $9,560,774,000 | -6.1% | 211,428 | -14.7% | 0.20% | -4.7% |
| Q1 2016 | $10,186,649,000 | +51.7% | 247,971 | +40.8% | 0.21% | +47.9% |
| Q4 2015 | $6,717,109,000 | +145.9% | 176,071 | +111.7% | 0.14% | +111.8% |
| Q3 2015 | $2,732,167,000 | -50.8% | 83,171 | +4.7% | 0.07% | -44.7% |
| Q2 2015 | $5,557,407,000 | -0.2% | 79,471 | -2.2% | 0.12% | -0.8% |
| Q1 2015 | $5,567,064,000 | +173.5% | 81,271 | +192.6% | 0.12% | +169.6% |
| Q4 2014 | $2,035,337,000 | -32.8% | 27,771 | -34.1% | 0.05% | -31.3% |
| Q3 2014 | $3,026,613,000 | +4.2% | 42,171 | +5.0% | 0.07% | +9.8% |
| Q2 2014 | $2,904,363,000 | +94.5% | 40,171 | +87.1% | 0.06% | +74.3% |
| Q4 2013 | $1,493,308,000 | +73.9% | 21,471 | +64.3% | 0.04% | +45.8% |
| Q3 2013 | $858,634,000 | +11.0% | 13,071 | +17.0% | 0.02% | +4.3% |
| Q2 2013 | $773,815,000 | – | 11,171 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |